Vascular liver disorders (I): Diagnosis, treatment and prognosis of Budd-Chiari syndrome

Netherlands Journal of Medicine

Volumn 66, Issue 8, 2008, Pages 334-339

  Hoekstra, J ^a   Janssen, H L A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Anticoagulation; Budd Chiari syndrome (BCS); Hepatic vein thrombosis; Myeloproliferative disorder (MPD); Transjugular intrahepatic portosystemic shunt (TIPS)

Indexed keywords

ANTICOAGULANT AGENT; DIURETIC AGENT; FIBRINOLYTIC AGENT; JANUS KINASE 2;

ABDOMINAL PAIN; ANTICOAGULANT THERAPY; ASCITES; BUDD CHIARI SYNDROME; CLINICAL FEATURE; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; FIBRINOLYTIC THERAPY; GENE MUTATION; HEPATOMEGALY; HUMAN; INFERIOR CAVA VEIN; LIVER ANGIOGRAPHY; LIVER FAILURE; LIVER TRANSPLANTATION; MYELOPROLIFERATIVE DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PORTOSYSTEMIC ANASTOMOSIS; PROGNOSIS; REVIEW; RISK FACTOR; THROMBOSIS; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; TREATMENT INDICATION; TREATMENT RESPONSE; VEIN OCCLUSION;

ANTICOAGULANTS; BUDD-CHIARI SYNDROME; HUMANS; PROGNOSIS; RISK FACTORS;

EID: 54349122531     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. Janssen HL, Garcia-Pagan JC, Elias E, Mentha G, Hadengue A, Valla DC. Budd-Chiari syndrome: a review by an expert panel. J Hepatol 2003;38:364-71.
2. DeLeve LD, Shulman HM, McDonald GB. Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). Semin Liver Dis 2002;22:27-42.
3. Budd G. On diseases of the liver. Philadelphia: Lea and Blanchard, 1846.
4. Chiari H. Ueber die selbständige Phlebitis obliterans der Haubtstämme der Venae hepaticae als Todesursache. Beitr Pathol Anat Allg Pathol 1899;26:1-18.
5. Cazals-Hatem D, Vilgrain V, Genin P, et al. Arterial and portal circulation and parenchymal changes in Budd-Chiari syndrome: a study in 17 explanted livers. Hepatology (Baltimore, Md.) 2003;37:510-9.
6. Mahmoud AE, Helmy AS, Billingham L, Elias E. Poor prognosis and limited therapeutic options in patients with Budd-Chiari syndrome and portal venous system thrombosis. Eur J Gastroenterol Hepatol 1997;9:485-9.
7. Murad SD, Valla DC, de Groen PC, et al. Pathogenesis and treatment of Budd-Chiari syndrome combined with portal vein thrombosis. Am J Gastroenterol 2006;101:83-90.
8. Holland-Fischer P, Gronbaek H, Astrup L, Keiding S, Nielsen DT, Vilstrup H. Budd-Chiari and inferior caval vein syndromes due to membranous obstruction of the liver veins: successful treatment with angioplasty and transcaval transjugular intrahepatic porto-systemic shunt. Scand J Gastroenterol 2004;39:1025-8.
9. Valla DC. Hepatic vein thrombosis (Budd-Chiari syndrome). Semin Liver Dis 2002;22:5-14.
10. Dilawari JB, Bambery P, Chawla Y, et al. Hepatic outflow obstruction (Budd-Chiari syndrome). Experience with 177 patients and a review of the literature. Medicine (Baltimore) 1994;73:21-36.
11. Langlet P, Escolano S, Valla D, et al. Clinicopathological forms and prognostic index in Budd-Chiari syndrome. J Hepatol 2003;39:496-501.
12. Zeitoun G, Escolano S, Hadengue A, et al. outcome of Budd-Chiari syndrome: a multivariate analysis of factors related to survival including surgical portosystemic shunting. Hepatology (Baltimore, Md.) 1999;30:84-9.
13. Murad SD, Valla DC, de Groen PC, et al. Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome. Hepatology (Baltimore, Md.) 2004;39:500-8.
14. Hadengue A, Poliquin M, Vilgrain V, et al, The changing scene of hepatic vein thrombosis: recognition of asymptomatic cases. Gastroenterology 1994;106:1042-7.
15. Ludwig J, Hashimoto E, McGill DB, van Heerden JA. Classification of hepatic venous outflow obstruction: ambiguous terminology of the Budd-Chiari syndrome. Mayo Clin Proc 1990;65:51-5.
16. Janssen HL, Meinardi JR, Vleggaar FP, et al. Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study. Blood 2000;96:2364-8.
17. Deltenre P, Denninger MH, Hillaire S, et al. Factor V Leiden related Budd-Chiari syndrome. Gut 2001;48:264-8.
18. Valla D, Casadevall N, Lacombe C, et al. Primary myeloproliferative disorder and hepatic vein thrombosis. A prospective study of erythroid colony formation in vitro in 20 patients with Budd-Chiari syndrome. Ann Intern Med 1985;103:329-34.
19. Murad SD, Plessier A, Hernandez-Guerra M, et al. Prospective follow-up study on 163 patients with Budd-Chiari syndrome: Results from the European network for vascular disorders of the liver (EN-VIE). J Hepatol 2007;46:S4.
20. Denninger MH, Chait Y, Casadevall N, et al. Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology (Baltimore, Md.) 2000;31:587-91.
21. Smalberg JH, Murad SD, Braakman E, Valk PJ, Janssen HL, Leebeek FW. Myeloproliferative disease in the pathogenesis and survival of Budd-Chiari syndrome. Haematologica 2006;91:1712-3.
22. Kiladjian JJ, Cervantes F, Leebeek FWG, et al. Role of JAK 2 mutation detection in budd-chiari syndrome (BCS) and portal vein thrombosis (PVT) associated to MPD. Blood 2006;16;108:116a-a.
23. Bolondi L, Gaiani S, Li Bassi S, et al. Diagnosis of Budd-Chiari syndrome by pulsed Doppler ultrasound. Gastroenterology 1991;100(5 Pt 1):1324-31.
24. Millener P, Grant EG, Rose S, et al. Color Doppler imaging findings in patients with Budd-Chiari syndrome: correlation with venographic findings. AJR Am J Roentgenol 1993;161:307-12.
25. Brancatelli G, Vilgrain V, Federle MP, et al. Budd-Chiari syndrome: spectrum ofimaging findings. AJR Am J Roentgenol 2007;188:W168-76.
26. Buckley O, J OB, Snow A, et al. Imaging of Budd-Chiari syndrome. Eur Radiol 2007 Aug;17:2071-8.
27. Tang TJ, Batts KP, de Groen PC, et al. The prognostic value of histology in the assessment of patients with Budd-Chiari syndrome. J Hepatol 2001;35:338-43.
28. Tanaka M, Wanless IR. Pathology of the liver in Budd-Chiari syndrome: portal vein thrombosis and the histogenesis of veno-centric cirrhosis, veno-portal cirrhosis, and large regenerative nodules. Hepatology (Baltimore, Md.) 1998;27:488-96.
29. Brancatelli G, Federle MP, Grazioli L, Golfieri R, Lencioni R. Large regenerative nodules in Budd-Chiari syndrome and other vascular disorders of the liver: CT and MR imaging findings with clinicopathologic correlation. AJR Am J Roentgenol 2002;178:877-83.
30. Vilgrain V, Lewin M, Vons C, et al. Hepatic nodules in Budd-Chiari syndrome: imaging features. Radiology 1999;210:443-50.
31. McNamara C, Juneja S, Wolf M, Grigg A. Portal or hepatic vein thrombosis as the first presentation of a myeloproliferative disorder in patients with normal peripheral blood counts. Clin Lab Haematol 2002;24:239-42.
32. Hirshberg B, Shouval D, Fibach E, Friedman G, Ben-Yehuda D. Flow cytometric analysis of autonomous growth of erythroid precursors in liquid culture detects occult polycythemia vera in the Budd-Chiari syndrome. J Hepatol 2000;32:574-8.
33. Baxter EJ, Scott LM, Campbell PJ, et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 2005;365:1054-61.
34. Kralovics R, Passamonti F, Buser AS, et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 2005;352:1779-90.
35. Janssen HL, Leebeek FW. JAK2 mutation: The best diagnostic tool for myeloproliferative disease in splanchnic vein thrombosis? Hepatology (Baltimore, Md.) 2006;44:1391-3.
36. Patel RK, Lea NC, Heneghan MA, et al. Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome. Gastroenterology 2006;130:2031-8.
37. Hemming AW, Langer B, Greig P, Taylor BR, Adams R, Heathcote EJ. Treatment of Budd-Chiari syndrome with Portosystemic shunt or liver transplantation. Am J Surg 1996;171:176-80; discussion 80-1.
38. Panis Y, Belghiti J, Valla D, Benhamou JP, Fekete F. Portosystemic shunt in Budd-Chiari syndrome: long-term survival and factors affecting shunt patency in 25 patients in Western countries. Surgery 1994;115:276-81.
39. Shaked A, Goldstein RM, Klintmalm GB, Drazan K, Husberg B, Busuttil RW. Portosystemic shunt versus orthotopic liver transplantation for the Budd-Chiari syndrome. Surg Gynecol Obstet 1992;174:453-9.
40. Orloff MJ, Daily PO, Orloff SL, Girard B, Orloff MS. A 27-year experience with surgical treatment of Budd-Chiari syndrome. Ann Surg 2000;232:340-52.
41. Plessier A, Sibert A, Consigny Y, et al. Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome. Hepatology (Baltimore, Md.) 2006;44:1308-16.
42. Fisher NC, McCafferty I, Dolapci M, et al. Managing Budd-Chiari syndrome: a retrospective review of percutaneous hepatic vein angioplasty and surgical shunting. Gut 1999;44:568-74.
43. Valla D, Hadengue A, el Younsi M, et al. Hepatic venous outflow block caused by short-length hepatic vein stenoses. Hepatology (Baltimore, Md.) 1997;25:814-9.
44. Ringe B, Lang H, Oldhafer KJ, et al. Which is the best surgery for Budd-Chiari syndrome: venous decompression or liver transplantation? A single-center experience with 50 patients. Hepatology (Baltimore, Md.) 1995;21:1337-44.
45. Bachet JB, Condat B, Hagege H, et al. Long-term portosystemic shunt patency as a determinant of outcome in Budd-Chiari syndrome. J Hepatol 2007;46:60-8.
46. Perello A, Garcia-Pagan JC, Gilabert R, et al. TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy. Hepatology (Baltimore, Md.) 2002;35:132-9.
47. Rossle M, Olschewski M, Siegerstetter V, Berger E, Kurz K, Grandt D. The Budd-Chiari syndrome: outcome after treatment with the transjugular intrahepatic portosystemic shunt. Surgery 2004;135:394-403.
48. Raffa S, Heydtmann M, Plessier A, et al. Treatment of Budd-Chiari syndrome with tips. Long-term results in 124 patients and evaluation of prognostic factors. J Hepatol 2007;46:S36-7.
49. Mentha G, Giostra E, Majno PE, et al. Liver transplantation for Budd-Chiari syndrome: A European study on 248 patients from 51 centres. J Hepatol 2006;44(3):520-8.
50. Ulrich F, Pratschke J, Neumann U, et al. Eighteen years of liver transplantation experience in patients with advanced Budd-Chiari syndrome. Liver Transpl 2008;14:144-50.
51. Segev DL, Nguyen GC, Locke JE, et al. Twenty years of liver transplantation for Budd-Chiari syndrome: a national registry analysis. Liver Transpl 2007;13:1285-94.
52. Valla DC. Thrombosis and anticoagulation in liver disease. Hepatology (Baltimore, Md.) 2008;47:1384-93.
53. Powell-Jackson PR, Melia W, Canalese J, Pickford RB, Portmann B, Williams R. Budd-Chiari Syndrome: clinical patterns and therapy. Q J Med 1982;51:79-88.